Mirum Pharmaceuticals Inc (MIRM)
$42.28 -$1.75 (-4.01%) 4:38 PM 12/12/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$2.14B -
Day's Range
$41.82 - $43.97 -
Volume
357,958 -
52 Week Low / High
$23.14 - $48.89 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
MIRM's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 7
- Strong Buy
- 4
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $55.43
- Target Price
Company News
-
Mirum (MIRM) Banks on Livmarli Sales Despite Recent Setback — Jan 23rd, 2024
Mirum Pharmaceuticals, Inc. MIRM develops novel therapies for treating rare liver diseases affecting children and adults. The company’s lead product, Livmarli (maralixibat), an orally administered ileal bile acid transporter (“IBAT”) inhibitor, is approved for the treatment of choles...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$